Strain-Specific Differences in the Genetic Control of Two Closely Related Mycobacteria

The host response to mycobacterial infection depends on host and pathogen genetic factors. Recent studies in human populations suggest a strain specific genetic control of tuberculosis. To test for mycobacterial-strain specific genetic control of susceptibility to infection under highly controlled experimental conditions, we performed a comparative genetic analysis using the A/J- and C57BL/6J-derived recombinant congenic (RC) mouse panel infected with the Russia and Pasteur strains of Mycobacterium bovis Bacille Calmette Guérin (BCG). Bacillary counts in the lung and spleen at weeks 1 and 6 post infection were used as a measure of susceptibility. By performing genome-wide linkage analyses of loci that impact on tissue-specific bacillary burden, we were able to show the importance of correcting for strain background effects in the RC panel. When linkage analysis was adjusted on strain background, we detected a single locus on chromosome 11 that impacted on pulmonary counts of BCG Russia but not Pasteur. The same locus also controlled the splenic counts of BCG Russia but not Pasteur. By contrast, a locus on chromosome 1 which was indistinguishable from Nramp1 impacted on splenic bacillary counts of both BCG Russia and Pasteur. Additionally, dependent upon BCG strain, tissue and time post infection, we detected 9 distinct loci associated with bacillary counts. Hence, the ensemble of genetic loci impacting on BCG infection revealed a highly dynamic picture of genetic control that reflected both the course of infection and the infecting strain. This high degree of adaptation of host genetics to strain-specific pathogenesis is expected to provide a suitable framework for the selection of specific host-mycobacteria combinations during co-evolution of mycobacteria with humans.

[1]  P. Gros,et al.  Pyruvate kinase deficiency in mice protects against malaria , 2003, Nature Genetics.

[2]  Tim W. Overton,et al.  Point mutations in the DNA- and cNMP-binding domains of the homologue of the cAMP receptor protein (CRP) in Mycobacterium bovis BCG: implications for the inactivation of a global regulator and strain attenuation. , 2005, Microbiology.

[3]  T. Gingeras,et al.  Detection of deleted genomic DNA using a semiautomated computational analysis of GeneChip data. , 2000, Genome research.

[4]  L. Laroche,et al.  Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. , 2001, Genomics.

[5]  Priscille Brodin,et al.  Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti , 2002, Molecular microbiology.

[6]  C. Dye,et al.  Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness , 2006, The Lancet.

[7]  M. Behr,et al.  The in vitro evolution of BCG vaccines. , 2003, Vaccine.

[8]  M. Behr,et al.  A historical and molecular phylogeny of BCG strains. , 1999, Vaccine.

[9]  J. Blackwell,et al.  BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies , 2002, The Lancet.

[10]  E. Schurr Is susceptibility to tuberculosis acquired or inherited? , 2007, Journal of internal medicine.

[11]  Stefan Niemann,et al.  Variable host-pathogen compatibility in Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Behr,et al.  TB: Screening for Responses to a Vile Visitor , 2010, Cell.

[13]  O. Werz,et al.  ALOX5 variants associated with susceptibility to human pulmonary tuberculosis. , 2007, Human molecular genetics.

[14]  A. Hart,et al.  Recombinant congenic strains — A new tool for analyzing genetic traits determined by more than one gene , 2004, Immunogenetics.

[15]  P. Hozák,et al.  Use of recombinant congenic strains in mapping disease-modifying genes. , 2004, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[16]  Julian Parkhill,et al.  Genome plasticity of BCG and impact on vaccine efficacy , 2007, Proceedings of the National Academy of Sciences.

[17]  D. Malo,et al.  Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg , 1993, Cell.

[18]  J. Mckinney,et al.  Role of KatG catalase‐peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst , 2004, Molecular microbiology.

[19]  C. Nathan,et al.  The Proteasome of Mycobacterium tuberculosis Is Required for Resistance to Nitric Oxide , 2003, Science.

[20]  M. Behr,et al.  Reduced expression of antigenic proteins MPB70 and MPB83 in Mycobacterium bovis BCG strains due to a start codon mutation in sigK , 2005, Molecular microbiology.

[21]  S. Kaufmann,et al.  Handbook of Tuberculosis , 2008 .

[22]  B. Taylor,et al.  Host response to infection with mycobacterium bovis (BCG) in mice: genetic study of natural resistance. , 1983, Advances in experimental medicine and biology.

[23]  Minjian Chen,et al.  Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death , 2008, The Journal of experimental medicine.

[24]  W. Altemeier,et al.  Natural Resistance to Infection. , 1961, Progress in surgery.

[25]  S. Fortune,et al.  Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair , 2009, Nature Immunology.

[26]  P. Small,et al.  Unique Gene Expression Profiles in Infants Vaccinated with Different Strains of Mycobacterium bovis Bacille Calmette-Guérin , 2007, Infection and Immunity.

[27]  Sebastien Gagneux,et al.  Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. , 2007, The Lancet. Infectious diseases.

[28]  M. Behr,et al.  A Point Mutation in the mma3 Gene Is Responsible for Impaired Methoxymycolic Acid Production in Mycobacterium bovis BCG Strains Obtained after 1927 , 2000, Journal of bacteriology.

[29]  R. Sladek,et al.  Identification of novel chromosomal regions associated with airway hyperresponsiveness in recombinant congenic strains of mice , 2010, Mammalian Genome.

[30]  P. Gros,et al.  Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. , 1981, Journal of immunology.

[31]  R. Wilkinson,et al.  The clinical consequences of strain diversity in Mycobacterium tuberculosis. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[32]  D. Sherman,et al.  Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation. , 2003, The Journal of infectious diseases.

[33]  C. Greenwood,et al.  Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. , 2000, American journal of human genetics.

[34]  M. Newport,et al.  Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy. , 2009, The Journal of infectious diseases.

[35]  B. Zhu,et al.  BCG Vaccines: Their mechanisms of attenuation and impact on safety and protective efficacy , 2009, Human vaccines.

[36]  David M. Tobin,et al.  The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans , 2010, Cell.

[37]  G. Mahairas,et al.  Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis , 1996, Journal of bacteriology.

[38]  K. Hasløv,et al.  Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. , 1999, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[39]  D. Malo,et al.  Pyruvate kinase deficiency confers susceptibility to Salmonella typhimurium infection in mice , 2007, The Journal of experimental medicine.

[40]  D. Sherman,et al.  Impact of Methoxymycolic Acid Production by Mycobacterium bovis BCG Vaccines , 2004, Infection and Immunity.

[41]  J. Farrar,et al.  The Influence of Host and Bacterial Genotype on the Development of Disseminated Disease with Mycobacterium tuberculosis , 2008, PLoS pathogens.

[42]  M. Reed,et al.  Major Mycobacterium tuberculosis Lineages Associate with Patient Country of Origin , 2009, Journal of Clinical Microbiology.

[43]  S. Niemann,et al.  Autophagy Gene Variant IRGM −261T Contributes to Protection from Tuberculosis Caused by Mycobacterium tuberculosis but Not by M. africanum Strains , 2009, PLoS pathogens.

[44]  E. Böttger,et al.  Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant , 2008, BMC Microbiology.